DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Zenith Drugs Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 3 hrs ago·10 Oct 2026, 7:05 am

Zenith Drugs

Zenith Drugs Limited has informed stock exchanges that it has received a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance is a standard requirement for entities that act as Depository Participants, facilitating the dematerialization of securities.

For investors, this update is a procedural confirmation. It indicates that the company has met the necessary regulatory standards for its depository operations, ensuring the smooth handling of share transactions. Such filings are routine and help maintain transparency in the market.

Investors should monitor the company's future announcements for any updates on business performance or new regulatory filings. While this specific news confirms compliance, it does not itself signal a change in the company's operational status or financial outlook.